Rituximab (anti-CD20) adjunctive therapy for Opsoclonus-Myoclonus syndrome

Michael R. Pranzatelli, Elizabeth D. Tate, Anna L. Travelstead, Jerry Barbosa, Robert A. Bergamini, Lucy Civitello, David N. Franz, Brian S. Greffe, Robin D. Hanson, Craig A. Hurwitz, Karen A. Kalinyak, Howard Kelfer, Yasmin Khakoo, John F. Mantovani, Stacy H. Nicholson, Joann M. Sanders, Stephen Wegner

Research output: Contribution to journalArticlepeer-review

114 Scopus citations

Fingerprint

Dive into the research topics of 'Rituximab (anti-CD20) adjunctive therapy for Opsoclonus-Myoclonus syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences